piribedil has been researched along with Hallucinations in 3 studies
Piribedil: A dopamine D2 agonist. It is used in the treatment of parkinson disease, particularly for alleviation of tremor. It has also been used for circulatory disorders and in other applications as a D2 agonist.
Hallucinations: Subjectively experienced sensations in the absence of an appropriate stimulus, but which are regarded by the individual as real. They may be of organic origin or associated with MENTAL DISORDERS.
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 1 (33.33) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 1 (33.33) | 29.6817 |
| 2010's | 1 (33.33) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Kölle, M | 1 |
| Lepping, P | 1 |
| Kassubek, J | 1 |
| Schönfeldt-Lecuona, C | 1 |
| Freudenmann, RW | 1 |
| Tan, EK | 1 |
| Ratnagopal, P | 1 |
| Han, SY | 1 |
| Wong, MC | 1 |
| Angrist, B | 1 |
| Thompson, H | 1 |
| Shopsin, B | 1 |
| Gershon, S | 1 |
1 trial available for piribedil and Hallucinations
| Article | Year |
|---|---|
Piribedil and bromocriptine in Parkinson's disease: a single-blind crossover study.
Topics: Administration, Oral; Aged; Antiparkinson Agents; Bromocriptine; Cross-Over Studies; Female; Halluci | 2003 |
2 other studies available for piribedil and Hallucinations
| Article | Year |
|---|---|
Delusional infestation induced by piribedil add-on in Parkinson's disease.
Topics: Antiparkinson Agents; Delusions; Drug Therapy, Combination; Ectoparasitic Infestations; Female; Hall | 2010 |
Clinical studies with dopamine-receptor stimulants.
Topics: Adult; Apomorphine; Blood Pressure; Dopamine; Female; Hallucinations; Humans; Male; Metoclopramide; | 1975 |